who shouldn't take tirzepatide Dosage Guide and Chart for Weight Loss Compounded Injectable Tirzepatide

Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds

The reconstitution process for compounded semaglutide also introduces a variable that brand-name formulations do not have

The Kaiser Family Foundation (KFF) maintains an updated tracker

Some people are reportedly taking a novel approach to using the blockbuster weight loss drug and a handful of doctors even say theyre doing it themselves